logo
Select company
Select metric
94.37%Cash to Assets Ratio
VS
Market
99
Sector
96
Industry
94
History
43
$ 0.6Close
$ 0.24 - $ 4.61 52-Week Range
Ticker Information

Ticker

LPTX

Company Name

LEAP THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LEAP THERAPEUTICS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LPTX - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 20.04M$ 18.91M94.37%
3/31/2025$ 34.88M$ 33.52M96.09%
12/31/2024$ 49.12M$ 48.07M97.86%
9/30/2024$ 65.05M$ 63.69M97.91%
6/30/2024$ 81.43M$ 79.34M97.44%
3/31/2024$ 57.96M$ 55.84M96.33%
12/31/2023$ 72.83M$ 71.61M98.33%
9/30/2023$ 83.05M$ 81.66M98.33%
6/30/2023$ 95.86M$ 92.35M96.34%
3/31/2023$ 106.55M$ 103.01M96.68%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for LEAP THERAPEUTICS INC is calculated as follows: CashnEq [ $ 58.92M ] / Assets [ $ 60.54M ]
(=) Cash to Assets [ 97.31% ]

LPTX - Cash to Assets Ratio, Last 5 years

94.37%

Minimum

Jun 30, 2025

98.33%

Maximum

Dec 31, 2023

97%

Average

97.2%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.76% with a standard deviation of 9.51%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.71%
average9.76%
median6.41%
std9.51%